Medline Industries Sustainability Profile
Medline Industries, Inc., a leading global manufacturer and distributor of healthcare supplies, is headquartered in the United States. Founded in 1910, the company has established a strong presence in North America and beyond, serving hospitals, nursing homes, and other healthcare facilities. Medline is renowned for its extensive range of products, including surgical instruments, medical apparel, and infection prevention solutions, all designed to enhance patient care and operational efficiency. With a commitment to innovation, Medline has achieved significant milestones, such as expanding its product lines and investing in advanced manufacturing technologies. The company holds a prominent market position, recognised for its quality and reliability, making it a trusted partner in the healthcare industry. Medline's dedication to customer service and tailored solutions further distinguishes it in a competitive landscape.
DitchCarbon Score
How does Medline Industries's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Medline Industries's score of 41 is higher than 63% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Medline Industries's reported carbon emissions
In 2023, Medline Industries reported total carbon emissions of approximately 7,278,301,000 kg CO2e globally, with significant contributions from Scope 1, 2, and 3 emissions. Specifically, Scope 1 emissions were about 173,837,000 kg CO2e, Scope 2 emissions totalled approximately 131,904,000 kg CO2e, and Scope 3 emissions accounted for around 6,972,560,000 kg CO2e. In the UK, the company reported total emissions of about 484,250 kg CO2e, with Scope 1 emissions at 1,330 kg CO2e, Scope 2 at 11,310 kg CO2e, and Scope 3 at 471,610 kg CO2e. Medline Industries has set ambitious climate commitments, aiming for a 30% reduction in Scope 1 and Scope 2 emissions from a 2023 baseline by 2030. Additionally, the company is committed to achieving Net Zero emissions by 2050, with projections indicating a reduction of total Scope 1 and Scope 2 emissions to 63 kg CO2e by 2030, representing a 42% absolute reduction. For Scope 3 emissions, limited to five sub-categories required by the NHS, the target is to reduce emissions to 513 kg CO2e by 2030, which is a 25% reduction. The emissions data for Medline Industries is cascaded from its parent company, Medline Industries, Inc., reflecting a corporate family relationship. The company is actively working towards its long-term climate goals, with a focus on both near-term and long-term emission reduction scenarios set for 2030 and 2050, respectively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2019 | 2020 | 2021 | 2023 | |
|---|---|---|---|---|---|---|
| Scope 1 | 45,201,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 81,309,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 3 | 90,611,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 0,000,000,000 |
How Carbon Intensive is Medline Industries's Industry?
How Carbon Intensive is Medline Industries's Location?
Medline Industries's Scope 3 Categories Breakdown
Medline Industries's Scope 3 emissions, which increased significantly last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 81% of Scope 3 emissions.
Top Scope 3 Categories
Medline Industries's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Medline Industries has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
